Gestational trophoblastic disease: origin of choriocarcinoma, invasive mole and choriocarcinoma associated with hydatidiform mole, and some immunologic aspects.
D000017:ABO Blood-Group System; D000293:Adolescent; D000328:Adult; D006063:Chorionic Gonadotropin / Q000652:urine; D002824:Chorionic Villi / Q000473:pathology; D005260:Female; D005315:Fetal Diseases / Q000209:etiology; D006680:HLA Antigens; D006801:Humans; D007109:Immunity; D007167:Immunotherapy; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology; D008875:Middle Aged; D009215:Myometrium / Q000473:pathology; D009362:Neoplasm Metastasis; D009378:Neoplasms, Multiple Primary / Q000209:etiology*; D010920:Placenta / Q000473:pathology; D011247:Pregnancy; D014328:Trophoblastic Neoplasms / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D014327:Trophoblasts / Q000473:pathology; D014594:Uterine Neoplasms / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy
D000017:ABO Blood-Group System; D006063:Chorionic Gonadotropin; D006680:HLA Antigens